South Africa new coronavirus variant rages alongside vaccine finance debate
“South Africa’s struggle with a new variant of COVID-19 coincides with a debate over how and who will pay for the vaccine. The business community may be one part of the solution, with the government saying the Pfizer jab is too expensive.”